Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where soggetti phrase all words 'PLACEBO-CONTROLLED EVALUATION' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 41 riferimenti
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Winokur, A; Gary, KA; Rodner, S; Rae-Red, C; Fernando, AT; Szuba, MR
      Depression, sleep physiology, and antidepressant drugs

      DEPRESSION AND ANXIETY
    2. Gilmore, A; Milne, R
      Methylphenidate in children with hyperactivity: review and cost-utility analysis

      PHARMACOEPIDEMIOLOGY AND DRUG SAFETY
    3. Brown, JL; Frew, AJ
      The efficacy of oromucosal immunotherapy in respiratory allergy

      CLINICAL AND EXPERIMENTAL ALLERGY
    4. Ghuman, JK; Ginsburg, GS; Subramaniam, G; Ghuman, HS; Kau, ASM; Riddle, MA
      Psychostimulants in preschool children with attention-deficit/hyperactivity disorder: Clinical evidence from a developmental disorders institution

      JOURNAL OF THE AMERICAN ACADEMY OF CHILD AND ADOLESCENT PSYCHIATRY
    5. Frew, AJ; Smith, HE
      Sublingual immunotherapy

      JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
    6. Bodor, N
      Retrometabolic drug design - novel aspects, future directions

      PHARMAZIE
    7. Wolraich, ML; Greenhill, LL; Pelham, W; Swanson, J; Wilens, T; Palumbo, D; Atkins, M; McBurnett, K; Bukstein, O; August, G
      Randomized, controlled trial of OROS methylphenidate once a day in children with attention-deficit/hyperactivity disorder

      PEDIATRICS
    8. Hoban, TF
      Sleeplessness in children with neurodevelopmental disorders - Epidemiologyand management

      CNS DRUGS
    9. White, SR; Yadao, CM
      Characterization of methylphenidate exposures reported to a regional poison control center

      ARCHIVES OF PEDIATRICS & ADOLESCENT MEDICINE
    10. Gara, L; Roberts, W
      Adverse response to methylphenidate in combination with valproic acid

      JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY
    11. Kleinhans, D; Zollner, I
      Sublingual allergen immunotherapy: estimation of efficacy

      ALLERGOLOGIE
    12. Bousquet, J; Demoly, P
      The future of immunotherapy.

      REVUE FRANCAISE D ALLERGOLOGIE ET D IMMUNOLOGIE CLINIQUE
    13. Mansi, C; Borro, P; Giacomini, M; Biagini, R; Mele, MR; Pandolfo, N; Savarino, V
      Comparative effects of levosulpiride and cisapride on gastric emptying andsymptoms in patients with functional dyspepsia and gastroparesis

      ALIMENTARY PHARMACOLOGY & THERAPEUTICS
    14. Bodor, N; Buchwald, P
      Soft drug design: General principles and recent applications

      MEDICINAL RESEARCH REVIEWS
    15. Noirey, N; Rougier, N; Andre, C; Schmitt, D; Vincent, C
      Langerhans-like dendritic cells generated from cord blood progenitors internalize pollen allergens by macropinocytosis, and part of the molecules areprocessed and can activate autologous naive T lymphocytes

      JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
    16. Bodor, N
      Recent advances in retrometabolic drug design and targeting approaches

      PHARMAZIE
    17. Howes, JF
      Loteprednol etabonate: a review of ophthalmic clinical studies

      PHARMAZIE
    18. Tripathi, RC; Parapuram, SK; Tripathi, BJ; Zhong, Y; Chalam, KV
      Corticosteroids and glaucoma risk

      DRUGS & AGING
    19. Mindell, JA; Owens, JA; Carskadon, MA
      Developmental features of sleep

      CHILD AND ADOLESCENT PSYCHIATRIC CLINICS OF NORTH AMERICA
    20. Stein, MA
      Unravelling sleep problems in treated and untreated children with ADHD

      JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY
    21. Diamond, IR; Tannock, R; Schachar, RJ
      Response to methylphenidate in children with ADHD and comorbid anxiety

      JOURNAL OF THE AMERICAN ACADEMY OF CHILD AND ADOLESCENT PSYCHIATRY
    22. Emilien, G; Maloteaux, JM; Geurts, M; Hoogenberg, K; Cragg, S
      Dopamine receptors - physiological understanding to therapeutic intervention potential

      PHARMACOLOGY & THERAPEUTICS
    23. Gaudilliere, B
      To market, to market - 1998

      ANNUAL REPORTS IN MEDICINAL CHEMISTRY, VOL 34
    24. Adesman, AR; Morgan, AM
      Management of stimulant medications in children with attention-deficit/hyperactivity disorder

      PEDIATRIC CLINICS OF NORTH AMERICA
    25. Overmeyer, S; Taylor, E
      Annotation: Principles of treatment for hyperkinetic disorder: Practice approaches for the UK

      JOURNAL OF CHILD PSYCHOLOGY AND PSYCHIATRY AND ALLIED DISCIPLINES
    26. Caldwell, D; Cohen, GR; Davis, J; DeBarge, LR; Foley, J; Foster, CS; Fox, K; Friedlaender, M; John, G; Kaufman, A; Nozik, R; Olander, K; Ostrov, C; Raizman, M; Rosenbaum, J; Sall, K; Sheppard, J; Stewart, D; Stewart, W; Tauber, J; Trocme, S; Zimmerman, P; Howes, J; Coultas, S; Crockett, RS; Novack, GD; Strahlman, ER; Neumann, R
      Controlled evaluation of loteprednol etabonate and prednisolone acetate inthe treatment of acute anterior uveitis

      AMERICAN JOURNAL OF OPHTHALMOLOGY
    27. OESTERHELD JR; KOFOED L; TERVO R; FOGAS B; WILSON A; FIECHTNER H
      EFFECTIVENESS OF METHYLPHENIDATE IN NATIVE-AMERICAN CHILDREN WITH FETAL ALCOHOL SYNDROME AND ATTENTION-DEFICIT HYPERACTIVITY DISORDER - A CONTROLLED PILOT-STUDY

      Journal of child and adolescent psychopharmacology
    28. FINDLING RL; DOGIN JW
      PSYCHOPHARMACOLOGY OF ADHD - CHILDREN AND ADOLESCENTS

      The Journal of clinical psychiatry
    29. DAY HD; ABMAYR SB
      PARENT REPORTS OF SLEEP DISTURBANCES IN STIMULANT-MEDICATED CHILDREN WITH ATTENTION-DEFICIT HYPERACTIVITY DISORDER

      Journal of clinical psychology
    30. SCHACHAR RJ; TANNOCK R; CUNNINGHAM C; CORKUM PV
      BEHAVIORAL, SITUATIONAL, AND TEMPORAL EFFECTS OF TREATMENT OF ADHD WITH METHYLPHENIDATE

      Journal of the American Academy of Child and Adolescent Psychiatry
    31. DULCAN M; DUNNE JE; AYRES W; ARNOLD V; BENSON RS; BERNET W; BUKSTEIN O; KINLAN J; LEONARD H; LICAMELE W; MCCLELLAN J; SLOAN LE; MILES CM
      PRACTICE PARAMETERS FOR THE ASSESSMENT AND TREATMENT OF CHILDREN, ADOLESCENTS, AND ADULTS WITH ATTENTION-DEFICIT HYPERACTIVITY-DISORDER/

      Journal of the American Academy of Child and Adolescent Psychiatry
    32. MUSTEN LM; FIRESTONE P; PISTERMAN S; BENNETT S; MERCER J
      EFFECTS OF METHYLPHENIDATE ON PRESCHOOL-CHILDREN WITH ADHD - COGNITIVE AND BEHAVIORAL FUNCTIONS

      Journal of the American Academy of Child and Adolescent Psychiatry
    33. PATRICK KS; MARKOWITZ JS
      PHARMACOLOGY OF METHYLPHENIDATE, AMPHETAMINE ENANTIOMERS AND PEMOLINEIN ATTENTION-DEFICIT HYPERACTIVITY DISORDER

      Human psychopharmacology
    34. RAPPLEY MD
      SAFETY ISSUES IN THE USE OF METHYLPHENIDATE - AN AMERICAN PERSPECTIVE

      Drug safety
    35. EFRON D; JARMAN F; BARKER M
      SIDE-EFFECTS OF METHYLPHENIDATE AND DEXAMPHETAMINE IN CHILDREN WITH ATTENTION-DEFICIT HYPERACTIVITY DISORDER - A DOUBLE-BLIND, CROSSOVER TRIAL

      Pediatrics
    36. PRINCE JB; WILENS TE; BIEDERMAN J; SPENCER TJ; WOZNIAK JR
      CLONIDINE FOR SLEEP DISTURBANCES ASSOCIATED WITH ATTENTION-DEFICIT HYPERACTIVITY DISORDER - A SYSTEMATIC CHART REVIEW OF 62 CASES

      Journal of the American Academy of Child and Adolescent Psychiatry
    37. CORAZZA GR; BIAGI F; ALBANO O; PORRO GB; CHELI R; MAZZACCA G; MIGLIO F; NACCARATO R; QUAGLINO D; SURRENTI C; VERME G; GASBARRINI G
      LEVOSULPIRIDE IN FUNCTIONAL DYSPEPSIA - A MULTICENTRIC DOUBLE-BLIND, CONTROLLED TRIAL

      The Italian Journal of Gastroenterology
    38. STEIN MA; BLONDIS TA; SCHNITZLER ER; OBRIEN T; FISHKIN J; BLACKWELL B; SZUMOWSKI E; ROIZEN NJ
      METHYLPHENIDATE DOSING - TWICE-DAILY VERSUS 3 TIMES DAILY

      Pediatrics
    39. BLUM NJ; MAUK JE; MCCOMAS JJ; MACE FC
      SEPARATE AND COMBINED EFFECTS OF METHYLPHENIDATE AND A BEHAVIORAL INTERVENTION ON DISRUPTIVE BEHAVIOR IN CHILDREN WITH MENTAL-RETARDATION

      Journal of applied behavior analysis
    40. FISHER R; BLUM D
      CLOBAZAM, OXCARBAZEPINE, TIAGABINE, TOPIRAMATE, AND OTHER NEW ANTIEPILEPTIC DRUGS

      Epilepsia
    41. FISHER RS
      EMERGING ANTIEPILEPTIC DRUGS

      Neurology


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 31/10/20 alle ore 18:29:50